EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bayesian Sample Size Determination Using Commensurate Priors to Leverage Preexperimental Data

Haiyan Zheng iD, Thomas Jaki, James M S Wason iD

Biometrics · 01.06.2023 · 79 (2) · 669-683

DOI: 10.1111/biom.13649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biometrics, online erschienen am 06.03.2022. Verfasst von Haiyan Zheng und 2 weiteren Autor:innen. Beteiligte Einrichtung: MRC Biostatistics Unit, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Cancer Research UK, National Institute for Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper develops Bayesian sample size formulae for experiments comparing two groups, where relevant preexperimental information from multiple sources can be incorporated in a robust prior to support both the design and analysis. We use commensurate predictive priors for borrowing of information and further place Gamma mixture priors on the precisions to account for preliminary belief about the pairwise (in)commensurability between parameters that underpin the historical and new experiments. Averaged over the probability space of the new experimental data, appropriate sample sizes are found according to criteria that control certain aspects of the posterior distribution, such as the coverage probability or length of a defined density region. Our Bayesian methodology can be applied to circumstances that compare two normal means, proportions, or event times. When nuisance parameters (such as variance) in the new experiment are unknown, a prior distribution can further be specified based on preexperimental data. Exact solutions are available based on most of the criteria considered for Bayesian sample size determination, while a search procedure is described in cases for which there are no closed-form expressions. We illustrate the application of our sample size formulae in the design of clinical trials, where pretrial information is available to be leveraged. Hypothetical data examples, motivated by a rare-disease trial with an elicited expert prior opinion, and a comprehensive performance evaluation of the proposed methodology are presented.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignSample SizeBayes TheoremProbability

Stichwörter der Autor:innen

Bayesian experimental designshistorical datarare-disease trialsrobustnesssample size

Autor:innen und Institutionen

  • MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
  • Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Department of Mathematics and Statistics, Lancaster University, Lancaster, UK.

ORCID-Profile: Haiyan Zheng, James M S Wason

Förderung

  • Medical Research Council
  • Cancer Research UK
  • National Institute for Health Research

Zitieren

APA

Zheng, H., Jaki, T., & Wason, J. M. S. (2023). Bayesian Sample Size Determination Using Commensurate Priors to Leverage Preexperimental Data. Biometrics, 79(2), 669-683. https://doi.org/10.1111/biom.13649

Vancouver

Zheng H, Jaki T, Wason JMS. Bayesian Sample Size Determination Using Commensurate Priors to Leverage Preexperimental Data. Biometrics. 2023;79(2):669-683. doi:10.1111/biom.13649

BibTeX
@article{Zheng2023,
  author = {Zheng, Haiyan and Jaki, Thomas and Wason, James M S},
  title = {Bayesian Sample Size Determination Using Commensurate Priors to Leverage Preexperimental Data},
  journal = {Biometrics},
  year = {2023},
  volume = {79},
  number = {2},
  pages = {669--683},
  doi = {10.1111/biom.13649}
}
Kostenlos starten →